Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Zaloglanstat

😃Good
Catalog No. T39000Cas No. 1513852-12-4
Alias ISC27864

Zaloglanstat (ISC-27864) is a selective, orally active mPGES-1 inhibitor with an IC50 of 5 nM against human mPGES-1, demonstrating analgesic effects in osteoarthritis and inflammatory arthritis.

Zaloglanstat

Zaloglanstat

😃Good
Purity: 99.97%
Catalog No. T39000Alias ISC27864Cas No. 1513852-12-4
Zaloglanstat (ISC-27864) is a selective, orally active mPGES-1 inhibitor with an IC50 of 5 nM against human mPGES-1, demonstrating analgesic effects in osteoarthritis and inflammatory arthritis.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$165-In Stock
5 mg$413-In Stock
10 mg$689-In Stock
25 mg$1,450-In Stock
50 mg$1,960-In Stock
100 mg$2,630-In Stock
1 mL x 10 mM (in DMSO)$455-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.97%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Zaloglanstat (ISC-27864) is a selective, orally active mPGES-1 inhibitor with an IC50 of 5 nM against human mPGES-1, demonstrating analgesic effects in osteoarthritis and inflammatory arthritis.
In vitro
Zaloglanstat exhibits selective inhibitory effects on both recombinant mPGES-1 activity and IL-1β in A549 cells, with IC50 values of 5 nM for both, while showing no significant inhibition on COX-1 and COX-2 (IC₅₀ >10 μM) [1]. In IL-1β-induced A549 cell and Homo sapiens synovial fibroblast models, Zaloglanstat can dose-dependently inhibit PGE₂ release, with an IC₅₀ value below 10 nM [1].
SynonymsISC27864
Chemical Properties
Molecular Weight452.86
FormulaC21H20ClF3N4O2
Cas No.1513852-12-4
SmilesCC(C)(C)C(=O)NCc1ccc(Cl)c(c1)-c1nn(-c2ccc(cc2)C(F)(F)F)c(=O)[nH]1
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 200 mg/mL (441.64 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Corn Oil: 3.3 mg/mL (7.29 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2082 mL11.0409 mL22.0819 mL110.4094 mL
5 mM0.4416 mL2.2082 mL4.4164 mL22.0819 mL
10 mM0.2208 mL1.1041 mL2.2082 mL11.0409 mL
20 mM0.1104 mL0.5520 mL1.1041 mL5.5205 mL
50 mM0.0442 mL0.2208 mL0.4416 mL2.2082 mL
100 mM0.0221 mL0.1104 mL0.2208 mL1.1041 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Zaloglanstat | purchase Zaloglanstat | Zaloglanstat cost | order Zaloglanstat | Zaloglanstat chemical structure | Zaloglanstat in vitro | Zaloglanstat formula | Zaloglanstat molecular weight